AVENUE THERAPEUTICS, INC. (ATXI) IPO - S-1 Filing, Stock & Insider Activity
AVENUE THERAPEUTICS, INC. IPO - Status & S-1 Filing
- Ticker: ATXI
- Status: Registration withdrawn
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001644963 · View the S-1 on SEC EDGAR →
AVENUE THERAPEUTICS, INC. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
AVENUE THERAPEUTICS, INC. (ATXI) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every ATXI SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About AVENUE THERAPEUTICS, INC. (ATXI)
AVENUE THERAPEUTICS, INC. trades under the ticker ATXI. InsiderAlpha tracks 3 primary SEC Form 4 filings from 2 reporting insiders for ATXI since 2024, sourced directly from SEC EDGAR.
| SEC CIK | 0001644963 |
|---|
Recent ATXI Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Neil Herskowitz | Director | S - Open-market sale | 23 | $2.00 | $46 | SEC | |
| Jay D. Kranzler | Director | S - Open-market sale | 61 | $2.24 | $137 | SEC | |
| Jay D. Kranzler | Director | P - Open-market purchase | 497 | $2.50 | $1K | SEC | |
| Jay D. Kranzler | Director | P - Open-market purchase | 3 | $2.40 | $7 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for AVENUE THERAPEUTICS, INC. (ATXI). Updated in real time as new filings are submitted to the SEC.
Recent ATXI Form 8-K Material Events
- - Item 1.01, 8.01, 9.01 · Contract · positive [SEC]
Avenue Therapeutics entered into an exclusive worldwide license agreement with Duke University on February 18, 2026, to develop and commercialize ATX-04 (clenbuterol) for lysosomal storage diseases, with initial focus on Pompe disease as an adjunct to enzyme replacement therapy.
Recent Insider Filings
- - Neil Herskowitz (Director)
- - Jay D. Kranzler (Director)
- - Jay D. Kranzler (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ATXI insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ATXI Insider Trading - FAQ
- What is the latest insider trade for ATXI?
- AVENUE THERAPEUTICS, INC. (ATXI) had 0 insider filings in the last 90 days, with the most recent on 2024-12-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ATXI stock?
- 0 insider purchases of ATXI were filed in the last 90 days.
- How many insiders are selling ATXI stock?
- 0 insider sales of ATXI were filed in the last 90 days.
- Where can I see ATXI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ATXI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $AVAT Avalanche Treasury Corp
- $AVAX Grayscale Avalanche Staking ETF
- $AVEX AEVEX Corp.
- $AVG ANEW HEALTH Ltd
- $AVLN Avalyn Pharma Inc.
- $AVNI ARVANA INC
- $AVR Anteris Technologies Global Corp.
- $AZIO AZIO AI HOLDINGS, INC.
- $AZN ASTRAZENECA PLC
- $AZTR Azitra, Inc.
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ATXI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.